Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis
Open Access
- 1 February 2017
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 17 (2) , 184-193
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- In VitroCardiovascular Effects of Dihydroartemisin-Piperaquine Combination Compared with Other AntimalarialsAntimicrobial Agents and Chemotherapy, 2012
- Randomized, Double-Blind, Placebo-Controlled Trial of Monthly versus Bimonthly Dihydroartemisinin-Piperaquine Chemoprevention in Adults at High Risk of MalariaAntimicrobial Agents and Chemotherapy, 2012
- Prevalence of the Congenital Long-QT SyndromeCirculation, 2009
- The clinical efficacy of artemether/lumefantrine (Coartem®)Malaria Journal, 2009
- Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in ChildrenPLOS ONE, 2009
- Artemisinin-based combination therapy for treating uncomplicated malariaCochrane Database of Systematic Reviews, 2009
- Antimicrobial-Associated QT Interval Prolongation: Pointes of InterestClinical Infectious Diseases, 2006
- Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparisonThe Lancet, 2006
- What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse dataStatistics in Medicine, 2004
- QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazoleThe American Journal of Cardiology, 1987